Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CareDx (CDNA)
NASDAQ:CDNA
CareDx (CDNA) Stock Price & Analysis
695 Followers
CDNA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.80 - $12.93
Previous Close$8.28
Volume274.93K
Average Volume (3M)905.16K
Market Cap
$421.99M
Enterprise Value$189.79M
Total Cash (Recent Filing)$268.18M
Total Debt (Recent Filing)$29.25M
Price to Earnings (P/E)-2.3
Beta1.66
Next Earnings
May 02, 2024EPS Estimate
-$0.47Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.55
Shares Outstanding51,778,523
10 Day Avg. Volume663,812
30 Day Avg. Volume905,156
Standard Deviation0.20
R-Squared0.14
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)2.32
Price to Sales (P/S)1.33
Price to Cash Flow (P/CF)-12.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.64
Enterprise Value/Gross Profit0.91
Enterprise Value/Ebitda-2.47
Forecast
1Y Price Target
$15.00Price Target Upside84.05% Upside
Rating ConsensusHold
Number of Analyst Covering4
CareDx News
PremiumCompany Announcements
CareDx Appoints John W. Hanna as New CEO and Board Member
PremiumCompany Announcements
CareDx Enhances Board with Financial Expert Riggsbee
PremiumCompany Announcements
CareDx Unveils Updated Financial Health and Strategy PresentationBulls Say, Bears Say
Bulls Say
EarningsCareDx delivered a slight top-line revenue beat in Q4 and initiated a 2024 revenue guide above consensus at the midpoint.
Financial HealthIt appears cash burn came in around ~$7M, which is a good improvement from the previous quarter's $12M. The company repurchased 2.8M shares for $26M.
Product GrowthThe recent Billing Article update from CMS is a generally bullish signal, indicating that strong lobbying may influence CMS.
Bears Say
EarningsNet loss was $118.1M, or ($2.21) per share, significantly higher than the estimated loss of $22.2M.
Leadership ConcernsAnother key item before becoming more positive on the stock is resolution of the CEO search.
Legal IssuesJury decision in patent infringement case awards significant damages—CareDx to seek judicial review.
---
Ownership Overview
18.23% Insiders
28.88% Mutual Funds
45.00% Other Institutional Investors
7.89% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CDNA FAQ
What was CareDx’s price range in the past 12 months?
CareDx lowest stock price was $4.80 and its highest was $12.93 in the past 12 months.
What is CareDx’s market cap?
Currently, no data Available
When is CareDx’s upcoming earnings report date?
CareDx’s upcoming earnings report date is May 02, 2024 which is in 13 days.
How were CareDx’s earnings last quarter?
CareDx released its earnings results on Feb 28, 2024. The company reported -$2.21 earnings per share for the quarter, missing the consensus estimate of -$0.447 by -$1.763.
Is CareDx overvalued?
According to Wall Street analysts CareDx’s price is currently Undervalued.
Does CareDx pay dividends?
CareDx does not currently pay dividends.
What is CareDx’s EPS estimate?
CareDx’s EPS estimate is -$0.47.
How many shares outstanding does CareDx have?
CareDx has 51,778,522 shares outstanding.
What happened to CareDx’s price movement after its last earnings report?
CareDx reported an EPS of -$2.21 in its last earnings report, missing expectations of -$0.447. Following the earnings report the stock price went up 9.465%.
Which hedge fund is a major shareholder of CareDx?
Among the largest hedge funds holding CareDx’s share is ARK Investment Management LLC. It holds CareDx’s shares valued at 86M.
---
CareDx Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$15.00 (84.05% Upside)
$15.00 (84.05% Upside)
Blogger Sentiment
Neutral
CDNA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 76.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 11.2%
Last 30 Days ▼ 11.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-11.53%
12-Months-Change
Fundamentals
Return on Equity
-54.98%
Trailing 12-Months
Asset Growth
-13.60%
Trailing 12-Months
Company Description
CareDx
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.
---
CDNA Earnings Call
Q4 2024
0:00 / 0:00
---
CDNA Stock 12 Months Forecast
Average Price Target
$15.00
▲(84.05% Upside)
Technical Analysis
Best Analysts Covering CDNA
1 Year
1 Year Success Rate
3/18 ratings generated profit
1 Year Average Return
-21.58%
upgraded a buy rating 8 months ago
Copying Andrew Cooper's trades and holding each position for 1 Year would result in 16.67% of your transactions generating a profit, with an average return of -21.58% per trade.
---